What’s Behind EcoR1’s Healthy Returns

The one-time II Rising Star posted another strong gain in a year when many other life sciences hedge funds lost money.

Stephen Taub January 21, 2022

Nicky Loh/Bloomberg

EcoR1 Capital has once again posted strong results.The life sciences fund headed by Oleg Nodelman was up 29 percent last year, according to an investor.This is especially impressive given that 2021 was a rough year for many life sciences hedge funds, especially those that load

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.03 build:2025-12-12 Login